Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson's Q3 DES sales slump 36 percent
Johnson & Johnson's Q3 DES sales slump 36 percent
Johnson & Johnson's Q3 DES sales slump 36 percent
Submitted by
moderatora
on October 19, 2010 - 12:27pm
Source:
Mass Device
News Tags:
JNJ
Cordis
drug eluting stents
Headline:
Johnson & Johnson's Q3 DES sales slump 36 percent
Do Not Allow Advertisers to Use My Personal information
